Milestone Pharmaceuticals News

Milestone Pharmaceuticals | EFFECT: Others

Nov 25 06:17 ET

Milestone Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Nov 12 16:44 ET

Milestone Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 12 16:40 ET

Milestone Pharmaceuticals | 8-K: Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Nov 12 09:37 ET

Milestone Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 09:30 ET

Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(5.2%),Millennium Group Management LLC(5.2%), etc.

Oct 29 16:35 ET

Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director PAPA JOSEPH C

Sep 5 16:44 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PAPA JOSEPH C

Sep 5 16:44 ET

Milestone Pharmaceuticals | 8-K: Current report

Sep 4 08:10 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Saik Andrew

Aug 29 16:21 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Giles Lisa M.

Aug 29 16:21 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fischer Seth H. Z.

Aug 29 16:21 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director TOMSICEK MICHAEL JOHN

Aug 29 16:21 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James

Aug 29 16:21 ET

Milestone Pharmaceuticals | 8-K: Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Aug 8 16:33 ET

Milestone Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8 16:21 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Saik Andrew

Jul 17 16:22 ET

Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Saik Andrew

Jul 17 16:22 ET

Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Duty Stuart

Jul 17 16:18 ET

Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duty Stuart

Jul 17 16:17 ET